Nrx pharmaceuticals announces agreement with lifesci associates to provide financial services and support

Industry veteran richard narido joins the nrx pharmaceuticals management team radnor, pa. , sept. 14, 2023 /prnewswire/ -- nrx pharmaceuticals, inc. (nasdaq: nrxp) ("nrx pharmaceuticals" or the "company"), a clinical-stage biopharmaceutical company, today announced that it has entered into an agreement (the "agreement") with ls associates, a division of lifesci advisors, llc ("lsa"), pursuant to which lsa will provide certain consulting services to the company, including but not limited to, arranging for the provision of the company's interim chief financial officer.
NRXP Ratings Summary
NRXP Quant Ranking